Swiss Takeover Board proceeding regarding potential mandatory tender offer extended to Mrs. Kun Shen

Tel Aviv / Zurich, 13 December 2017 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced that it has been informed by the Swiss Takeover Board that the proceeding regarding the potential duty of Himalaya (Cayman Island) TMT Fund and/or Himalaya Asset Management Ltd. and/or Mr. Xu Xiang and/or GF Fund Management Co. Ltd. and/or Zhuhai Hokai Medical Instruments Co. Ltd. and/or Mrs. Cai Mengke to make a mandatory tender offer according to art. 135 of the Swiss Financial Market Infrastructure Act (see SHL's press release dated 11 August 2017) has been extended to Mrs. Kun Shen. Mrs. Kun Shen, who had purchased Himalaya (Cayman Island) TMT Fund's shares in SHL and has since then increased her stake to 25.02 % of the voting rights in SHL (see SHL's press release of 6 November 2017), indicates that she is an investor and director of Himalaya (Cayman Island) TMT Fund, and she and Mr. Xiang Xu, managing director of Himalaya Asset Management Ltd., are married and parents to SHL's board member Ms. Shenlu Xu.

For further information, please contact:

Martin Meier-Pfister, IRF Communications, phone : +41 43 244 81 40, shl@irfcom.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our website at www.shl-telemedicine.com.